Merger

Search documents
Carlisle Companies (CSL) 2025 Earnings Call Presentation
2025-06-25 11:56
Investor Presentation May 2025 Forward Looking Statements & Non-GAAP Financial Measures This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements generally use words such as "expect," "foresee," "anticipate," "believe," "project," "should," "estimate," "will," "plans," "intends," "forecast," and similar expressions, and reflect our expectations concerning the future. Such statements are made based on known eve ...
Phibro Animal Health: The Animal Is Unleashed
Seeking Alpha· 2025-06-25 08:19
Group 1 - Phibro Animal Health (NASDAQ: PAHC) announced a significant acquisition from Zoetis (ZTS) aimed at driving business momentum [1] - The investment group "Value In Corporate Events" focuses on identifying opportunities in IPOs, mergers & acquisitions, earnings reports, and corporate capital allocation [1] - The service covers approximately 10 major events monthly to find optimal investment opportunities [1]
Glacier Bancorp (GBCI) Earnings Call Presentation
2025-06-25 06:51
Established 1913 June 24, 2025 Acquisition of Forward-Looking Statements This presentation may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, statements about Glacier Bancorp, Inc. ("the Company")'s plans, objectives, expectations and intentions that are not historical facts, and other statements identified by words such as "expects," "anticipates," "intends," "plans," "believes, ...
DSS, Inc.’s Subsidiary, Impact BioMedical Inc., Announces Strategic Merger
Globenewswire· 2025-06-24 12:30
"This transaction reflects our continued commitment to unlocking shareholder value through the strategic development and monetization of our subsidiaries," said Jason Grady, CEO of DSS, Inc. "We believe the combination of Impact's disruptive pipeline with Dr. Ashleys' global infrastructure and commercial expertise will establish a robust, scalable biopharmaceutical platform. It further validates our strategy of creating long- term value by preparing our key assets for public market growth." NEW YORK, June 2 ...
Webuy Global Ltd. Appoints Award-Winning Corporate Leader Heng Wee Koon as Independent Director
Globenewswire· 2025-06-24 12:00
Singapore, June 24, 2025 (GLOBE NEWSWIRE) -- Webuy Global Ltd. (Nasdaq: WBUY) (Webuy or the “Company”), a leading community e-commerce and travel platform in Southeast Asia, previously announced via Form 6-K the appointment of Mr. Heng Wee Koon as Independent Director and Chair of the Compensation Committee. The Company now takes the opportunity to highlight Mr. Heng’s distinguished credentials and the strategic value he brings to the Company. Mr. Heng brings over 25 years of leadership experience spanning ...
Kroger's Next Chapter: Navigating The Post-Merger Landscape
Seeking Alpha· 2025-06-23 18:04
It's time for an update on The Kroger Co. (NYSE: KR ). I last covered the stock in December of 2024 . This article came out right after the merger breakup between the companyI'm a full time value investor and writer who enjoys using classical value ratios to pick my portfolio. My previous working background is in private credit and CRE mezzanine financing for a family office. I'm also a fluent Mandarin speaker in both business and court settings, previously serving as a court interpreter. I have spent a goo ...
Novartis announces expiration of HSR waiting period of Regulus Therapeutics tender offer
Globenewswire· 2025-06-23 05:00
Core Points - Novartis announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act in relation to its tender offer to acquire Regulus Therapeutics Inc. [1][2] - The tender offer includes $7.00 in cash per share and one contingent value right (CVR) per share, which represents the right to receive an additional $7.00 upon achieving a regulatory milestone [1][2]. - The expiration of the HSR Act waiting period is a necessary condition for the completion of the merger agreement dated April 29, 2025 [2]. Tender Offer Details - The offer will expire one minute past 11:59 p.m. New York City Time on June 24, 2025, unless extended or terminated earlier [2]. - The completion of the transaction requires validly tendered shares that, along with shares owned by Novartis and its subsidiaries, represent at least one more than 50% of the total outstanding shares [2]. Additional Information - Novartis and its subsidiary filed a tender offer statement with the U.S. Securities and Exchange Commission (SEC), and Regulus filed a solicitation/recommendation statement regarding the tender offer [3]. - Investors are encouraged to read the tender offer materials and the solicitation/recommendation statement for important information before making decisions [4].
Bank of New York Mellon approached Northern Trust about potential merger: report
New York Post· 2025-06-22 20:52
Group 1 - Bank of New York Mellon Corp. expressed interest in merging with Northern Trust, with discussions between their chief executives taking place [1][3] - No formal offer was discussed during the conversations, but a future formal bid from BNY is possible [3][6] - BNY has a market capitalization of $65.55 billion, while Northern Trust's market cap stands at $21.76 billion [3] Group 2 - In May, BNY received a license to establish a regional headquarters in Saudi Arabia, indicating its strategy to enhance its presence in the financial hub [4] - Both BNY and Northern Trust have not provided comments regarding the merger discussions [5]
Why GMS Stock Is Soaring Today
The Motley Fool· 2025-06-20 19:24
A bidding war appears to be brewing for building products distribution company GMS (GMS 24.74%), and investors are excited by the possibilities.Shares of GMS jumped 26% on Friday morning after the company was put in play by an unsolicited suitor. A building products bidding war?GMS is a construction products distributor and tool supplier for consumer and commercial customers. Late Wednesday, QXO (QXO 5.29%) proposed acquiring the business for about $5 billion, or $95.20 per share in cash, a premium of 27% t ...
Logan Ridge Finance (LRFC) 2025 Extraordinary General Meeting Transcript
2025-06-20 15:30
Logan Ridge Finance (LRFC) 2025 Extraordinary General Meeting June 20, 2025 10:30 AM ET Speaker0 Good morning, ladies and gentlemen, and welcome to the special meeting of stockholders of Logan Ridge Finance Corporation. My name is Ted Goldthorpe, Director, President and Chief Executive Officer of the company, and I will act as Chair of this meeting. We're excited to be hosting our virtual meeting, which allows us to be more inclusive and reach a greater number of stockholders. We have stockholders attending ...